COVID‐19: Virology, biology and novel laboratory diagnosis
Background At the end of December 2019, a novel coronavirus tentatively named SARS‐
CoV‐2 in Wuhan, a central city in China, was announced by the World Health Organization …
CoV‐2 in Wuhan, a central city in China, was announced by the World Health Organization …
[HTML][HTML] Cytokine storm in COVID-19:“when you come out of the storm, you won't be the same person who walked in”
In December 2019, a novel coronavirus, COVID-19, was discovered to be the causal agent
of a severe respiratory infection named SARS-CoV-2, and it has since been recognized …
of a severe respiratory infection named SARS-CoV-2, and it has since been recognized …
[HTML][HTML] Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
SMR Hashemian, R Aliannejad, M Zarrabi… - Stem cell research & …, 2021 - Springer
Background Acute respiratory distress syndrome (ARDS) is a fatal complication of
coronavirus disease 2019 (COVID-19). There are a few reports of allogeneic human …
coronavirus disease 2019 (COVID-19). There are a few reports of allogeneic human …
[HTML][HTML] Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: A randomized controlled trial
Background and aims The main causes of death in patients with severe Coronavirus
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …
[HTML][HTML] Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
C Lee, WJ Choi - Archives of pharmacal research, 2021 - Springer
The novel beta coronavirus (SARS-CoV-2, designated as COVID-19) that is responsible for
severe acute respiratory syndrome has devastated the global economy and health care …
severe acute respiratory syndrome has devastated the global economy and health care …
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID‐19: Design and rationale for the …
M Kosiborod, O Berwanger, GG Koch… - Diabetes, Obesity …, 2021 - Wiley Online Library
Abstract Aims Coronavirus disease 2019 (COVID‐19) is caused by a novel severe acute
respiratory syndrome coronavirus 2. It can lead to multiorgan failure, including respiratory …
respiratory syndrome coronavirus 2. It can lead to multiorgan failure, including respiratory …
[HTML][HTML] Organoids: a novel modality in disease modeling
Limitations of monolayer culture conditions have motivated scientists to explore new models
that can recapitulate the architecture and function of human organs more accurately. Recent …
that can recapitulate the architecture and function of human organs more accurately. Recent …
Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation
The outbreak of SARS-CoV-2 infection has presented the world with an urgent demand for
advanced diagnostics and therapeutics to prevent, treat and control the spread of infection …
advanced diagnostics and therapeutics to prevent, treat and control the spread of infection …
[HTML][HTML] Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis
The outbreak of novel coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) virus continually led to infect a large …
respiratory syndrome coronavirus-2 (SARS-CoV-2) virus continually led to infect a large …
[HTML][HTML] Diagnosing the novel SARS-CoV-2 by quantitative RT-PCR: variations and opportunities
HG Barreto, FA de Pádua Milagres… - Journal of Molecular …, 2020 - Springer
The world is currently facing a novel viral pandemic (SARS-CoV-2), and large-scale testing
is central to decision-making for the design of effective policies and control strategies to …
is central to decision-making for the design of effective policies and control strategies to …